140 related articles for article (PubMed ID: 3107804)
61. Identification of a BALB/c H-2Ld gene by DNA-mediated gene transfer.
Goodenow RS; McMillan M; Orn A; Nicolson M; Davidson N; Frelinger JA; Hood L
Science; 1982 Feb; 215(4533):677-9. PubMed ID: 7058331
[TBL] [Abstract][Full Text] [Related]
62. Increased sensitivity to TNF-mediated cytotoxicity of BL6 melanoma cells after H-2Kb gene transfection.
Kim M; Herberman R; Gorelik E
J Immunol; 1993 Oct; 151(7):3467-77. PubMed ID: 8376787
[TBL] [Abstract][Full Text] [Related]
63. Partial suppression of anchorage-independent growth and tumorigenicity in immunodeficient mice by transfection of the H-2 class I gene H-2Ld into a human colon cancer cell line (HCT).
Gattoni-Celli S; Willett CG; Rhoads DB; Simon B; Strauss RM; Kirsch K; Isselbacher KJ
Proc Natl Acad Sci U S A; 1988 Nov; 85(22):8543-7. PubMed ID: 3186742
[TBL] [Abstract][Full Text] [Related]
64. In vivo H-2K and H-2D antigen expression in two allogeneic mouse tumours of low immunogenicity.
Ashley MP; Kotlarski I
Immunol Cell Biol; 1987 Aug; 65 ( Pt 4)():323-8. PubMed ID: 3679289
[TBL] [Abstract][Full Text] [Related]
65. Lewis lung carcinoma (3LL) cells treated in vitro with ultraviolet radiation show reduced metastatic ability due to an augmented immunogenicity.
Peppoloni S; Herberman RB; Gorelik E
Clin Exp Metastasis; 1987; 5(1):43-56. PubMed ID: 3829496
[TBL] [Abstract][Full Text] [Related]
66. Heterogeneity in surface antigen of cell lines and clones from a murine carcinoma.
Kiger N
Int J Cancer; 1985 Jan; 35(1):129-34. PubMed ID: 3881361
[TBL] [Abstract][Full Text] [Related]
67. IFN-alpha 1 gene transfection completely abolishes the tumorigenicity of murine B16 melanoma cells in allogeneic DBA/2 mice and decreases their tumorigenicity in syngeneic C57BL/6 mice.
Kaido T; Bandu MT; Maury C; Ferrantini M; Belardelli F; Gresser I
Int J Cancer; 1995 Jan; 60(2):221-9. PubMed ID: 7829220
[TBL] [Abstract][Full Text] [Related]
68. Transfection of major histocompatibility complex class I and class II genes causes tumour rejection.
Ostrand-Rosenberg S; Clements VK; Thakur A; Cole GA
J Immunogenet; 1989; 16(4-5):343-9. PubMed ID: 2639907
[TBL] [Abstract][Full Text] [Related]
69. H-2Db gene transfer into highly metastatic D122 cells results in tumor rejection in allogeneic recipients, but does not affect metastasis in syngeneic recipients. Implications for mechanisms of allorejection.
Plaksin D; Gelber C; Eisenbach L
Int J Cancer; 1992 Nov; 52(5):771-7. PubMed ID: 1428231
[TBL] [Abstract][Full Text] [Related]
70. MHC antigens expressed on 3LL metastatic variants: correlation with the expression of a TSP-180 protein.
Sacchi A; Falcioni R; Tibursi G; Apollonj Ghetti C
Adv Exp Med Biol; 1988; 233():141-50. PubMed ID: 3223380
[TBL] [Abstract][Full Text] [Related]
71. The class I-b molecule Qa-1 forms heterodimers with H-2Ld and a novel 50-kD glycoprotein encoded centromeric to I-E beta.
Wolf PR; Cook RG
J Exp Med; 1995 Feb; 181(2):657-68. PubMed ID: 7836920
[TBL] [Abstract][Full Text] [Related]
72. Identification of a surface antigen, common to murine lung and Lewis lung carcinoma, by monoclonal antibody.
Hadas E; Hurwitz E; Eshhar Z
Int J Cancer; 1984 Mar; 33(3):369-74. PubMed ID: 6365802
[TBL] [Abstract][Full Text] [Related]
73. Imbalance of MHC class I expression in 3LL tumour cells.
Benihoud K; Lecerf JM; Bobé P; Kiger N
Eur J Immunogenet; 1991; 18(5-6):355-65. PubMed ID: 1772880
[TBL] [Abstract][Full Text] [Related]
74. Monoclonal antibodies (IgM) against a murine carcinoma, Lewis lung carcinoma (3LL): production, purification and in vitro selectivity.
Midoux P; Roche AC; Monsigny M
Immunol Lett; 1984; 8(3):131-6. PubMed ID: 6500631
[TBL] [Abstract][Full Text] [Related]
75. Molecular studies of murine mutant BALB/c-H-2dm2 define a deletion of several class I genes including the entire H-2Ld gene.
Rubocki RJ; Hansen TH; Lee DR
Proc Natl Acad Sci U S A; 1986 Dec; 83(24):9606-10. PubMed ID: 2879284
[TBL] [Abstract][Full Text] [Related]
76. Monoclonal antibodies to Lewis lung carcinoma.
Ukei S; Saiki I; Azuma I
J Cancer Res Clin Oncol; 1985; 110(2):103-9. PubMed ID: 4044623
[TBL] [Abstract][Full Text] [Related]
77. Immunogenicity of H-2 positive and H-2 negative clones of a mouse tumour, GR9.
Garrido ML; Pérez M; Delgado C; Rojano J; Algarra I; Garrido A; Garrido F
J Immunogenet; 1986; 13(2-3):159-67. PubMed ID: 3819450
[TBL] [Abstract][Full Text] [Related]
78. Hormonal regulation of cell surface expression of the major histocompatibility antigen H-2Ld in transfected cells.
Ponta H; Ball R; Steinmetz M; Groner B
EMBO J; 1985 Dec; 4(13A):3447-53. PubMed ID: 3004961
[TBL] [Abstract][Full Text] [Related]
79. Differences in cell surface antigens of tumor metastases and those of the local tumor.
Fogel M; Gorelik E; Segal S; Feldman M
J Natl Cancer Inst; 1979 Mar; 62(3):585-8. PubMed ID: 84091
[TBL] [Abstract][Full Text] [Related]
80. H-2Ld antigen encoded by a recombinant retrovirus genome is expressed on the surface of infected cells.
Weis JH; Reiss CS; Mulligan RC; Burakoff SJ; Seidman JG
Mol Cell Biol; 1985 Jun; 5(6):1379-84. PubMed ID: 2993861
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
